STEPHEN LAMB: Open Payments
NPI 1609086057 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 27 payments from 5 companies in 2025. Trend: 2023 $493 · 2024 $387 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 16 | $302 |
| Otsuka America Pharmaceutical, Inc. | 7 | $205 |
| Alkermes, Inc. | 2 | $51 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: HETLIOZ, REXULTI, FANAPT, ARISTADA, Auvelity, CAPLYTA.
Industry payments across KY — which companies pay providers there.
